The role of PLZF in human myeloid development

Annals of the New York Academy of Sciences

Volumn 1176, Issue , 2009, Pages 150-153

  Dick, John E ^a,b,c   Doulatov, Sergei ^b,c  

^a Toronto Medical Discovery Tower ^*  (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Human; Myelopoiesis; PLZF

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PLZF; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

CONFERENCE PAPER; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; MYELOPOIESIS; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

EID: 70349836510     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04965.x     Document Type: Conference Paper

References (29)

1. Dick, J.E. & T. Lapidot. 2005. Biology of normal and acute myeloid leukemia stem cells. Int. J. Hematol. 82: 389-396.
2. Kondo, M., A. Wagers, M. Manz, et al. 2003. Biology of hematopoietic stem cells and progenitors:Implications for clinical application. Annu. Rev. Immunol. 21: 759-806.
3. Rawlings, D.J., S. Quan, Q.L. Hao, et al. 1997. Differentiation of human CD34 + CD38- cord blood stem cells into B cell progenitors in vitro. Exp. Hematol. 25: 66-72.
4. Hao, Q.L., E.M. Smogorzewska, L.W. Barsky & G.M. Crooks. 1998. In vitro identification of single CD34 + CD38- cells with both lymphoid and myeloid potential. Blood 91: 4145-4151.
5. Gan, O.I., C. Dorrell, D.S. Pereira, et al. 1999. Characterization and retroviral transduction of an early human lymphomyeloid precursor assayed in non-switched long-term culture on murine stroma. Exp. Hematol. 27: 1097-1106.
6. La Motte-Mohs, R.N., E. Herer & J.C. Zuniga-Pflucker. 2005. Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 105: 1431-1439.
7. Laiosa, C.V., M. Stadtfeld & T. Graf. 2006. Determinants of lymphoid-myeloid lineage diversification. Annu. Rev. Immunol. 24: 705-738.
8. Laslo, P., C.J. Spooner, A. Warmflash, et al. 2006. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 126: 755-766.
9. Dick, J.E. 2008. Stem cell concepts renew cancer research. Blood 112: 4793-4807.
10. Wang, J.C., C. Dorrell, C.Y. Ito, et al. 2001. Normal and leukemic human stem cells assayed in immune-deficient mice. In Hematopoiesis: A Developmental Approach. L.I. Zon, Ed.: 99-118. Oxford University Press. New York.
11. Dorrell, C., K. Takenaka, M.D. Minden, et al. 2004. Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are in-fluenced by Ras activity and farnesyltransferase inhibition. Mol. Cell. Biol. 24: 6993-7002.
12. Pereira, D.S., C. Dorrell, C.Y. Ito, et al. 1998. Retro-viral transduction of TLS-ERG initiates a leuke-mogenic program in normal human hematopoietic cells. Proc. Natl. Acad. Sci. USA 95: 8239-8244.
13. Wang JC, Warner JK, Erdmann N, et al. 2005. Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells. Proc. Natl. Acad. Sci. USA. 104: 14398-14403.
14. Warner, J.K., J.C. Wang, K. Takenaka, et al. 2005. Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells. Leukemia 19: 1794-1805.
15. Kennedy, J.A., F. Barabe, B.J. Patterson, et al. 2006. Expression of TEL-JAK2 in primary human hematopoietic cells drives erythropoietin-independent erythropoiesis and induces myelofibro-sis in vivo. Proc. Natl. Acad. Sci. USA 103: 16930-16935.
16. Barna, M., N. Hawe, L. Niswander & P.P. Pandolfi. 2000. Plzf regulates limb and axial skeletal patterning. Nat. Genet. 25: 166-172.
17. Buaas, F.W., A.L. Kirsh, M. Sharma, et al. 2004. Plzf is required in adult male germ cells for stem cell self-renewal. Nat. Genet. 36: 647-652.
18. Costoya, J.A., R.M. Hobbs, M. Barna, et al. 2004. Essential role of Plzf in maintenance of spermatogonial stem cells. Nat. Genet. 36: 653-659.
19. Labbaye, C., I. Spinello, M.T. Quaranta, et al. 2008. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat. Cell. Biol. 10: 788-801.
20. Savage, A.K., M.G. Constantinides, J. Han, et al. 2008. The transcription factor PLZF directs the ef-fector program of the NKT cell lineage. Immunity 29: 391-403.
21. Kovalovsky, D., O.U. Uche, S. Eladad, et al. 2008. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9: 1055-1064.
22. Chen, Z., N.J. Brand, A. Chen, et al. 1993. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promye-locytic leukaemia. EMBO J. 12: 1161-1167.
23. Shaknovich, R., P.L. Yeyati, S. Ivins, et al. 1998. The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis. Mol. Cell. Biol. 18: 5533-5545.
24. Ward, J.O., M.J. McConnell, G.W. Carlile, et al. 2001. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor. Blood 98: 3290-3300.
25. McConnell, M.J., N. Chevallier, W. Berkofsky-Fessler, et al. 2003. Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression. Mol. Cell. Biol. 23: 9375-9388.
26. Hong, S.H., G. David, C.W. Wong, et al. 1997. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94: 9028-9033.
27. Barna M., T. Merghoub, J.A. Costoya, et al. 2002. Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling. Dev. Cell. 3: 499-510.
28. Rizzatti, E.G., A.B. Garcia, F.L. Portieres, et al. 2002. Expression of CD117 and CD11b in bone marrow can differentiate acute promyelocytic leukemia from recovering benign myeloid proliferation. Am. J. Clin. Pathol. 118: 31-37.
29. Rosenbauer, F. & D.G. Tenen. 2007. Transcription factors in myeloid development: balancing differentiation with transformation. Nat. Rev. Immunol. 7: 105-117.